Industry may rue its win against FDA.(US Food and Drug Administration)

From: Medical Marketing & Media | Date: September 1, 1999| Author: Dickinson, James G. | Copyright information

The First Amendment rules! After three years battling FDA encroachments on health product companies' free speech, the final victory that came in July in the Washington Legal Foundation's case against three FDA guidance documents surely seemed sweet indeed.

But it was almost immediately assailed by legal authorities as going too far. One even suggested that U.S. District Court Judge Royce G. Lamberth, a Reagan appointee who seems to delight in harassing the Clinton Admini...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

FDA oversight of 'off-label' drugs fading: Former court opponent of agency now in position to help ease rules for companies
Charleston Gazette ; WASHINGTON - In 1962, a Congress horrified that thousands of European babies had been deformed by the medication thalidomide ordered the Food and Drug Administration to make sure the same thing never happened in America. Congress gave the FDA the power to assess the safety and effectiveness of all
FDA's Winckler talks about the agency's goals
Drug Topics ; In September2006, Susan Winckler, R.Ph., J.D., joined the Food & Drug Administration as acting chief of staff. She had served as the American Pharmacists Association's staff counsel and VP for policy and communications. Drug Topics sat down with Winckler to get her answers to the following
One Man's Ode to the FDA; Agency Is Often Criticized, but Employees Sing Its Praises
The Washington Post ; "FDA Centennial Anthem" won't be mistaken for "The Star-Spangled Banner No bombs are bursting in air; instead, goods are made effective, safe and pure. Workers at the Food and Drug Administration are singing a new 126- word ode at awards ceremonies, picnics and commemorative events to mark the
FDA Nominee to Get Vote; Agency to Act on Plan B Pill
The Washington Post ; The nomination of Lester M. Crawford, the administration's embattled choice to head the Food and Drug Administration, got a boost yesterday when three senators agreed to lift their holds and allow a vote on the Senate floor. But the nomination still faces hurdles, as lawmakers have formally
FDA chief chosen amid troubles; President Bush taps acting commissioner Lester Crawford, as the agency faces criticism for handling of popular drugs.(USA)
The Christian Science Monitor ; Byline: Gregory M. Lamb Staff writer of The Christian Science Monitor With the heat turned up on the Food and Drug Administration regarding its failings as a consumer watchdog, the Bush administration has decided that the man already in place is the one to battle the blaze. The White House